Initiation of DNA replication within oriP is dispensable for stable replication of the latent Epstein-Barr virus chromosome after infection of established cell lines

Journal of Virology

Volumn 74, Issue 18, 2000, Pages 8563-8574

  Norio, P ^a   Schildkraut, C L ^a   Yates, J L ^a  

^a ALBERT EINSTEIN COLLEGE OF MEDICINE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

CIRCULAR DNA;

ARTICLE; B LYMPHOCYTE; BINDING SITE; CELL CYCLE S PHASE; CHROMOSOME; DNA REPLICATION; EPSTEIN BARR VIRUS; HUMAN; HUMAN CELL; LATENT VIRUS INFECTION; PLASMID; PRIORITY JOURNAL; VIRUS GENOME; VIRUS INFECTION;

BASE SEQUENCE; CHROMOSOMES; DNA REPLICATION; ELECTROPHORESIS, GEL, TWO-DIMENSIONAL; EPSTEIN-BARR VIRUS NUCLEAR ANTIGENS; GENOME, VIRAL; HERPESVIRUS 4, HUMAN; MUTATION; REPLICATION ORIGIN; SEQUENCE DELETION; TUMOR CELLS, CULTURED; VIRUS REPLICATION;

EID: 0033844279     PISSN: 0022538X     EISSN: None     Source Type: Journal    
DOI: 10.1128/JVI.74.18.8563-8574.2000     Document Type: Article

References (56)

1. Replication of latent Epstein-Barr virus genomes in Raji cells
2. The plasmid replicon of EBV consists of multiple cis-acting elements that facilitate DNA synthesis by the cell and a viral maintenance element
3. Participation of the human beta-globin locus control region in initiation of DNA replication
4. Optimal lengths for DNAs encapsidated by Epstein-Barr virus
5. The localization of replication origins on ARS plasmids in S. cerevisiae
6. Stability without a centromer
7. The Chinese hamster dihydrofolate reductase origin consists of multiple potential nascent-strand start sites
8. Mapping of replication initiation sites in mammalian genomes by two-dimensional gel analysis: Stabilization and enrichment of replication intermediates by isolation on the nuclear matrix
9. EBV-negative and -positive Burkitt cell lines variably express receptors for B-cell activation and differentiation
10. Epstein-Barr nuclear antigen 1 mediates a DNA loop within the latent replication origin of Epstein-Barr virus
11. The Epstein-Barr virus origin of plasmid replication, oriP, contains both the initiation and termination sites of DNA replication
12. Detection of circular and linear herpesvirus DNA molecules in mammalian cells by gel electrophoresis
13. Characteristics of a human cell line transformed by DNA from human adenovirus type 5
14. Genetic analysis of immortalizing functions of Epstein-Barr virus in human B lymphocytes
15. Identification and characterization of oriLyt, a lytic origin of DNA replication of Epstein-Barr virus
16. Sequence requirements of the Epstein-Barr virus latent origin of DNA replication
17. New Epstein-Barr virus variants from cellular subclones of P3J-HR-1 Burkitt lymphoma
18. Distal sequences, but not ori-beta/OBR-1, are essential for initiation of DNA replication in the Chinese hamster DHFR origin
19. Epstein-Barr-based episomal chromosomes shuttle 100 kb of self-replicating circular human DNA in mouse cells
20. Epstein-Barr virus and its replication
21. Mutants of Epstein-Barr virus with a selective marker disrupting the TP gene transform B cells and replicate normally in culture
22. Rep*: A viral element that can partially replace the origin of plasmid DNA synthesis of Epstein-Barr virus
23. Identification of primary initiation sites for DNA replication in the hamster dihydrofolate reductase gene initiation zone
24. Replication initiates at multiple locations on an autonomously replicating plasmid in human cells
25. Isolation of human sequences that replicate autonomously in human cells
26. Roles of nuclear structure in DNA replication
27. Epstein-Barr virus gene expression in oral hairy leukoplakia
28. Genetic evidence that EBNA-1 is needed for efficient, stable latent infection by Epstein-Barr virus
29. BHRF1 of Epstein-Barr virus, which is homologous to human proto-oncogene bcl2, is not essential for transformation of B ceils or for virus replication in vitro
30. Mapping sites of replication initiation and termination in circular viral genomes using two-dimensional gel electrophoresis
31. Initiation and termination of DNA replication in human rRNA genes
32. Initiation of latent DNA replication in the Epstein-Barr virus genome can occur at sites other than the genetically defined origin
33. Plasmid origin of replication of herpesvirus papio: DNA sequence and enhancer function
34. Mapping genetic elements of Epstein-Barr virus that facilitate extrachromosomal persistence of Epstein-Barr virus-derived plasmids in human cells
35. Release of infectious Epstein-Barr virus by transformed marmoset leukocytes
36. DNA of Epstein-Barr virus VIII: B95-8, the previous prototype, is an unusual deletion derivative
37. Sequence-specific DNA binding of the Epstein-Barr virus nuclear antigen (EBNA-1) to clustered sites in the plasmid maintenance region
38. A putative origin of replication of plasmids derived from Epstein-Barr virus is composed of two cis-acting components
39. The Epstein-Barr virus nuclear protein 1 promoter active in type I latency is autoregulated
40. Redefining the Epstein-Barr virus-encoded nuclear antigen EBNA-1 gene promoter and transcription initiation site in group I Burkitt lymphoma cell lines
41. The migration behaviour of DNA replicative intermediates containing an internal bubble analyzed by two-dimensional agarose gel electrophoresis
42. Identification of minimal oriP of Epstein-Barr virus required for DNA replication
43. Stable episomal maintenance of yeast artificial chromosomes in human cells
44. DNA looping between the origin of replication of Epstein-Barr virus and its enhancer site: Stabilization of an origin complex with Epstein-Barr nuclear antigen 1
45. Transforming functions associated with Epstein-Barr virus
46. Epstein-Barr virus-encoded small RNAs (EBERs) do not modulate interferon effects in infected lymphocytes
47. Recombinant Epstein-Barr virus with small RNA (EBER) genes deleted transforms lymphocytes and replicates in vitro
48. Second-site homologous recombination in Epstein-Barr virus: Insertion of type 1 EBNA 3 genes in place of type 2 has no effect on in vitro infection
49. Epstein-Barr virus recombinants from overlapping cosmid fragments
50. Multiple EBNA1-binding sites are required to form an EBNA1-dependent enhancer and to activate a minimal replicative origin within oriP of Epstein-Barr virus
51. A cis-acting element from the Epstein-Barr viral genome that permits stable replication of recombinant plasmids in latently infected cells
52. The minimal replicator of Epstein-Barr virus oriP
53. Epstein-Barr virus-derived plasmids replicate only once per cell cycle and are not amplified after entry, into cells
54. Stable replication of plasmids derived from Epstein-Barr virus in various mammalian cells
55. B-cell lines immortalized with an Epstein-Barr virus mutant lacking the Cp EBNA2 enhancer are biased toward utilization of the oriP-proximal EBNA gene promoter Wp1